US Stock MarketDetailed Quotes

RYTM Rhythm Pharmaceuticals

Watchlist
  • 52.850
  • -0.870-1.62%
Trading Mar 25 15:47 ET
3.34BMarket Cap-12.18P/E (TTM)

Rhythm Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
68.06%130.13M
72.61%41.83M
47.76%33.25M
51.28%29.08M
126.41%25.97M
227.56%77.43M
175.70%24.23M
425.30%22.5M
112.01%19.22M
665.62%11.47M
Operating revenue
68.06%130.13M
72.61%41.83M
47.76%33.25M
51.28%29.08M
126.41%25.97M
227.56%77.43M
175.70%24.23M
425.30%22.5M
112.01%19.22M
665.62%11.47M
Cost of revenue
43.71%13.37M
17.14%3.79M
58.71%3.83M
31.80%2.95M
97.54%2.81M
336.10%9.3M
214.49%3.23M
385.31%2.41M
491.53%2.24M
517.83%1.42M
Gross profit
71.39%116.76M
81.15%38.04M
46.44%29.42M
53.85%26.13M
130.49%23.16M
216.79%68.13M
170.56%21M
430.55%20.09M
95.50%16.99M
692.43%10.05M
Operating expense
51.40%382.26M
27.35%79.3M
14.46%73.31M
4.75%66.61M
160.55%163.05M
25.83%252.48M
24.87%62.27M
48.76%64.05M
18.23%63.59M
15.98%62.58M
Selling and administrative expenses
22.78%144.3M
17.78%38.13M
16.09%35.38M
21.20%36.42M
39.57%34.38M
27.71%117.53M
23.02%32.37M
38.91%30.48M
34.57%30.05M
14.85%24.63M
Research and development costs
76.33%237.96M
37.72%41.17M
12.99%37.93M
-9.98%30.19M
239.08%128.67M
24.23%134.95M
26.94%29.89M
58.98%33.57M
6.63%33.54M
16.72%37.95M
Operating profit
-44.02%-265.5M
0.02%-41.26M
0.15%-43.89M
13.14%-40.48M
-166.29%-139.89M
-2.90%-184.36M
1.99%-41.27M
-11.93%-43.95M
-3.34%-46.6M
0.30%-52.53M
Net non-operating interest income expense
-11,216.98%-5.89M
-164.30%-1.93M
-474.76%-1.19M
-517.07%-506K
-550.92%-1.71M
104.52%53K
-2,536.67%-731K
125.90%317K
-135.96%-82K
136.88%379K
Non-operating interest income
5.49%14.71M
-7.96%3.52M
16.96%4.05M
27.20%4.1M
-11.45%3.05M
246.12%13.95M
25.58%3.82M
276.74%3.47M
1,075.55%3.22M
2,050.00%3.44M
Non-operating interest expense
48.31%20.6M
19.71%5.45M
66.47%5.24M
39.36%4.6M
55.34%4.76M
167.10%13.89M
51.11%4.55M
46.88%3.15M
7,080.43%3.3M
--3.06M
Other net income (expense)
5,762.63%11.14M
-134.88%-195K
784.28%1.09M
54,229.41%9.2M
2,040.74%524K
124.05%190K
233.10%559K
57.03%-159K
87.22%-17K
88.41%-27K
Gain on sale of security
--8.9M
--0
----
--8.9M
----
----
----
----
----
----
Other non- operating income (expenses)
1,078.42%2.24M
-134.88%-195K
784.28%1.09M
1,876.47%302K
2,040.74%524K
124.05%190K
233.10%559K
57.03%-159K
87.22%-17K
88.41%-27K
Income before tax
-41.36%-260.26M
-4.69%-43.38M
-0.43%-43.99M
31.95%-31.78M
-170.36%-141.07M
-1.65%-184.11M
2.49%-41.44M
-7.18%-43.8M
-3.78%-46.7M
1.11%-52.18M
Income tax
-38.65%346K
-145.92%-90K
-193.48%-344K
479K
300K
564K
196K
368K
0
0
Net income
-41.11%-260.6M
-3.98%-43.29M
1.18%-43.64M
30.92%-32.26M
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.7M
1.11%-52.18M
Net income continuous Operations
-41.11%-260.6M
-3.98%-43.29M
1.18%-43.64M
30.92%-32.26M
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.7M
1.11%-52.18M
Minority interest income
Net income attributable to the parent company
-41.11%-260.6M
-3.98%-43.29M
1.18%-43.64M
30.92%-32.26M
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.7M
1.11%-52.18M
Preferred stock dividends
3.97M
1.3M
Other preferred stock dividends
Net income attributable to common stockholders
-43.26%-264.57M
-13.52%-47.26M
1.18%-43.64M
28.14%-33.56M
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.7M
1.11%-52.18M
Basic earnings per share
-35.63%-4.34
-2.86%-0.72
3.95%-0.73
32.93%-0.55
-155.43%-2.35
7.78%-3.2
6.67%-0.7
3.80%-0.76
7.87%-0.82
12.38%-0.92
Diluted earnings per share
-35.63%-4.34
-2.86%-0.72
3.95%-0.73
32.93%-0.55
-155.43%-2.35
7.78%-3.2
6.67%-0.7
3.80%-0.76
7.87%-0.82
12.38%-0.92
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 68.06%130.13M72.61%41.83M47.76%33.25M51.28%29.08M126.41%25.97M227.56%77.43M175.70%24.23M425.30%22.5M112.01%19.22M665.62%11.47M
Operating revenue 68.06%130.13M72.61%41.83M47.76%33.25M51.28%29.08M126.41%25.97M227.56%77.43M175.70%24.23M425.30%22.5M112.01%19.22M665.62%11.47M
Cost of revenue 43.71%13.37M17.14%3.79M58.71%3.83M31.80%2.95M97.54%2.81M336.10%9.3M214.49%3.23M385.31%2.41M491.53%2.24M517.83%1.42M
Gross profit 71.39%116.76M81.15%38.04M46.44%29.42M53.85%26.13M130.49%23.16M216.79%68.13M170.56%21M430.55%20.09M95.50%16.99M692.43%10.05M
Operating expense 51.40%382.26M27.35%79.3M14.46%73.31M4.75%66.61M160.55%163.05M25.83%252.48M24.87%62.27M48.76%64.05M18.23%63.59M15.98%62.58M
Selling and administrative expenses 22.78%144.3M17.78%38.13M16.09%35.38M21.20%36.42M39.57%34.38M27.71%117.53M23.02%32.37M38.91%30.48M34.57%30.05M14.85%24.63M
Research and development costs 76.33%237.96M37.72%41.17M12.99%37.93M-9.98%30.19M239.08%128.67M24.23%134.95M26.94%29.89M58.98%33.57M6.63%33.54M16.72%37.95M
Operating profit -44.02%-265.5M0.02%-41.26M0.15%-43.89M13.14%-40.48M-166.29%-139.89M-2.90%-184.36M1.99%-41.27M-11.93%-43.95M-3.34%-46.6M0.30%-52.53M
Net non-operating interest income expense -11,216.98%-5.89M-164.30%-1.93M-474.76%-1.19M-517.07%-506K-550.92%-1.71M104.52%53K-2,536.67%-731K125.90%317K-135.96%-82K136.88%379K
Non-operating interest income 5.49%14.71M-7.96%3.52M16.96%4.05M27.20%4.1M-11.45%3.05M246.12%13.95M25.58%3.82M276.74%3.47M1,075.55%3.22M2,050.00%3.44M
Non-operating interest expense 48.31%20.6M19.71%5.45M66.47%5.24M39.36%4.6M55.34%4.76M167.10%13.89M51.11%4.55M46.88%3.15M7,080.43%3.3M--3.06M
Other net income (expense) 5,762.63%11.14M-134.88%-195K784.28%1.09M54,229.41%9.2M2,040.74%524K124.05%190K233.10%559K57.03%-159K87.22%-17K88.41%-27K
Gain on sale of security --8.9M--0------8.9M------------------------
Other non- operating income (expenses) 1,078.42%2.24M-134.88%-195K784.28%1.09M1,876.47%302K2,040.74%524K124.05%190K233.10%559K57.03%-159K87.22%-17K88.41%-27K
Income before tax -41.36%-260.26M-4.69%-43.38M-0.43%-43.99M31.95%-31.78M-170.36%-141.07M-1.65%-184.11M2.49%-41.44M-7.18%-43.8M-3.78%-46.7M1.11%-52.18M
Income tax -38.65%346K-145.92%-90K-193.48%-344K479K300K564K196K368K00
Net income -41.11%-260.6M-3.98%-43.29M1.18%-43.64M30.92%-32.26M-170.94%-141.37M-1.97%-184.68M2.02%-41.63M-8.08%-44.16M-3.78%-46.7M1.11%-52.18M
Net income continuous Operations -41.11%-260.6M-3.98%-43.29M1.18%-43.64M30.92%-32.26M-170.94%-141.37M-1.97%-184.68M2.02%-41.63M-8.08%-44.16M-3.78%-46.7M1.11%-52.18M
Minority interest income
Net income attributable to the parent company -41.11%-260.6M-3.98%-43.29M1.18%-43.64M30.92%-32.26M-170.94%-141.37M-1.97%-184.68M2.02%-41.63M-8.08%-44.16M-3.78%-46.7M1.11%-52.18M
Preferred stock dividends 3.97M1.3M
Other preferred stock dividends
Net income attributable to common stockholders -43.26%-264.57M-13.52%-47.26M1.18%-43.64M28.14%-33.56M-170.94%-141.37M-1.97%-184.68M2.02%-41.63M-8.08%-44.16M-3.78%-46.7M1.11%-52.18M
Basic earnings per share -35.63%-4.34-2.86%-0.723.95%-0.7332.93%-0.55-155.43%-2.357.78%-3.26.67%-0.73.80%-0.767.87%-0.8212.38%-0.92
Diluted earnings per share -35.63%-4.34-2.86%-0.723.95%-0.7332.93%-0.55-155.43%-2.357.78%-3.26.67%-0.73.80%-0.767.87%-0.8212.38%-0.92
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Tesla
TSLA
286.200
Petroleo Brasileiro SA Petrobras
PBR
14.310
Adobe
ADBE
403.580
4
Ecopetrol
EC
10.310
5
Vale SA
VALE
10.090
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Earnings Season Underway
Earnings season is here. What to know?